Resources from the same session
Is a one size fits all approach still appropriate for NSCLS with an EGFR mutation, are all mutations equal?
Presenter: Joachim Aerts
Session: Lilly - Personalising and optimising treatment for metastatic NSCLC patients with EGFR and other co-occurring mutations
Resources:
Webcast
Identifying the clinical and disease characteristics of the high risk patient, what is the science telling us?
Presenter: Federico Cappuzzo
Session: Lilly - Personalising and optimising treatment for metastatic NSCLC patients with EGFR and other co-occurring mutations
Resources:
Webcast
Case study from the clinic – Potential patient profile and include sequencing and discuss with panel
Presenter: Chao-Hua Chiu
Session: Lilly - Personalising and optimising treatment for metastatic NSCLC patients with EGFR and other co-occurring mutations
Resources:
Webcast